CD274 and hepatocellular carcinoma: As shown in Figure 11A, we found that all five genes in the Tregs-associated signature were significantly associated with PD1 and PD-L1 expression not only in the TCGA cohort but also in 20 clinical HCC samples, suggesting that these genes may be targets for anti-PD1/PD-L1 immunotherapy.